Now showing items 1-1 of 1
A SMAP in the face for cancer.
(The Journal of clinical investigation, 2017-06)
Observed deficits in protein phosphatase 2A (PP2A) function in a variety of human cancers have stimulated drug discovery efforts aimed at restoring PP2A function to inhibit tumor growth. Work published by Sangodkar et al. ...